Patients with polycystic ovary syndrome(PCOS) are at high risk for iatrogenic ovarian hyperstimulation, and the FSH/LH ratio is usually decreased in PCOS and elevated in subjects with pituitary tumours, so attention should be paid to the diagnosis of these diseases. This evidence concerns the gene BRD2 and pituitary tumor.